Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:58:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a topic and included a new Resources link to Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T16:16:53.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T08:58:58.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T04:58:39.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Results posting details were added: Results First Submitted (2026-01-05), Results First Posted with QC Comments (2026-01-22), Results First Posted (2026-02-10), and associated PDFs such as the Study Protocol and Informed Consent Form.
    Difference
    3%
    Check dated 2026-02-11T16:22:28.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A site-wide notice about the lapse in government funding and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:44:28.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.